-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation